| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 4,773,000 | 4,817,000 | 4,852,000 | 4,863,000 | | Cost of Revenue |
-
| (9,061,000) | 8,595,000 | 466,000 | | | Gross Profit | 4,773,000 | 13,878,000 | (3,743,000) | 4,397,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,532,000 | 14,218,000 | (3,975,000) | 3,984,000 | | Non Recurring | (32,000) |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 273,000 | (340,000) | 232,000 | 413,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 273,000 | (340,000) | 232,000 | 413,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 273,000 | (340,000) | 232,000 | 413,000 | | Income Tax Expense | 65,000 | (130,000) | 62,000 | 140,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 208,000 | (210,000) | 170,000 | 273,000 | | | Non-recurring Events | | Discontinued Operations | 1,000 | 1,000 | 1,000 | (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 209,000 | (209,000) | 171,000 | 272,000 | | Preferred Stock And Other Adjustments | (1,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $208,000 | ($209,000) | $171,000 | $272,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
